Legend Biotech (LEGN) Invested Capital (2019 - 2024)
Legend Biotech (LEGN) has disclosed Invested Capital for 6 consecutive years, with $1.3 billion as the latest value for Q4 2024.
- For the quarter ending Q4 2024, Invested Capital fell 14.04% year-over-year to $1.3 billion, compared with a TTM value of $1.3 billion through Dec 2024, down 14.04%, and an annual FY2024 reading of $1.3 billion, down 14.04% over the prior year.
- Invested Capital was $1.3 billion for Q4 2024 at Legend Biotech, down from $1.5 billion in the prior quarter.
- Across five years, Invested Capital topped out at $1.5 billion in Q4 2023 and bottomed at $601.1 million in Q4 2020.
- Average Invested Capital over 5 years is $1.1 billion, with a median of $1.0 billion recorded in 2022.
- The sharpest move saw Invested Capital soared 281.9% in 2020, then dropped 14.04% in 2024.
- Year by year, Invested Capital stood at $601.1 million in 2020, then surged by 47.33% to $885.6 million in 2021, then grew by 16.12% to $1.0 billion in 2022, then surged by 45.99% to $1.5 billion in 2023, then fell by 14.04% to $1.3 billion in 2024.
- Business Quant data shows Invested Capital for LEGN at $1.3 billion in Q4 2024, $1.5 billion in Q4 2023, and $1.0 billion in Q4 2022.